Ketamine and the Psychedelic Renaissance: How It Compares to Psilocybin and MDMA in India- 2025 See more
FDA Approval of Spravato (Esketamine) for Treatment-Resistant Depression (TRD): A Psychiatrist’s Perspective See more
The Transformative Power of Awe in Ketamine Infusion Therapy: Insights from a Decade of Practice at Mind Brain Institute in 2025 See more
Unlocking Hope: The Therapeutic Integration of Ketamine Therapy for Treatment-Resistant Depression See more
Pioneering Single-Day Transcranial Magnetic Stimulation (TMS) Treatment for Depression and Beyond See more
Why Ketamine Treatment is Different at Mind Brain Institute, New Delhi for Depression, Anxiety, and OCD – 2025 See more
Transcranial Magnetic Stimulation (TMS): A Safer and Highly Effective Treatment for Depression, Anxiety, and OCD Compared to Medications – 2025 See more
